CJC-1295 5MG with DAC

CJC-1295 with DAC is a long-acting growth hormone-releasing hormone (GHRH) analog known for its ability to stimulate the body’s natural production of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) over an extended period, leading to sustained anabolic and recovery benefits. The Drug Affinity Complex (DAC) modification allows the peptide to bind to serum albumin, significantly prolonging its half-life to approximately 6–8 days, enabling once-weekly dosing and continuous elevation of GH and IGF-1 levels.

• Enhanced Muscle Growth and Fat Loss: By maintaining elevated GH and IGF-1 levels, CJC-1295 with DAC promotes muscle protein synthesis, supporting lean muscle mass gains and increasing lipolysis, which aids in fat metabolism and body recomposition.

• Improved Recovery and Tissue Repair: The sustained release of IGF-1 creates a favorable environment for the repair of tendons, ligaments, cartilage, and connective tissues, making it a popular choice in injury recovery protocols, especially when stacked with peptides like BPC-157 and TB500.

• Better Sleep Quality and Cellular Regeneration: Increased GH availability enhances deep sleep cycles, including REM and slow-wave sleep, which are critical for tissue repair, recovery, and overall cellular regeneration.

• Convenience and Reduced Injection Frequency: With a half-life of 6–8 days, users typically require only 1–2 injections per week, offering a more manageable regimen compared to short-acting alternatives.